TW200716098A - Acyltryptophanols - Google Patents

Acyltryptophanols

Info

Publication number
TW200716098A
TW200716098A TW095129439A TW95129439A TW200716098A TW 200716098 A TW200716098 A TW 200716098A TW 095129439 A TW095129439 A TW 095129439A TW 95129439 A TW95129439 A TW 95129439A TW 200716098 A TW200716098 A TW 200716098A
Authority
TW
Taiwan
Prior art keywords
acyltryptophanols
osteoporosis
men
women
prevention
Prior art date
Application number
TW095129439A
Other languages
Chinese (zh)
Inventor
Lars Wortmann
Arwed Cleve
Bernd Menzenbach
Hans-Peter Muhn
Gernot Langer
Anna Schrey
Ronald Kuehne
Marcus Koppitz
Dirk Kosemund
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200716098A publication Critical patent/TW200716098A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present patent application relates to acyltryptophanols of the general formula I, in which Q, X, Y, W, R1, R2, R3, R4, R5, R8 have the meanings stated in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
TW095129439A 2005-08-10 2006-08-10 Acyltryptophanols TW200716098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005038632A DE102005038632B4 (en) 2005-08-10 2005-08-10 Acyltryptophanole

Publications (1)

Publication Number Publication Date
TW200716098A true TW200716098A (en) 2007-05-01

Family

ID=37681170

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095129439A TW200716098A (en) 2005-08-10 2006-08-10 Acyltryptophanols

Country Status (7)

Country Link
AR (1) AR056190A1 (en)
DE (1) DE102005038632B4 (en)
DO (1) DOP2006000187A (en)
GT (1) GT200600365A (en)
PE (1) PE20070406A1 (en)
TW (1) TW200716098A (en)
UY (1) UY29737A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008025893B4 (en) * 2008-05-26 2014-09-18 Technische Universität Dresden Process for the preparation of fatty acid amides with saturated, unsaturated or hydroxy fatty acids

Also Published As

Publication number Publication date
GT200600365A (en) 2007-04-02
UY29737A1 (en) 2007-02-28
PE20070406A1 (en) 2007-05-12
AR056190A1 (en) 2007-09-26
DE102005038632B4 (en) 2008-03-27
DE102005038632A1 (en) 2007-02-15
DOP2006000187A (en) 2007-03-15

Similar Documents

Publication Publication Date Title
WO2007017289A3 (en) Acyltryptophanols for fertility control
WO2009016253A3 (en) Cyanomethyl substituted n-acyl tryptamines
PT1984357E (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
DE602004021472D1 (en) Pyrimiidinverbindungen
IL182317A0 (en) Cgrp receptor antagonists
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2007011023A (en) 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists.
TW201713640A (en) Bruton's tyrosine kinase inhibitors
EP1804919A4 (en) Cgrp receptor antagonists
WO2006099268A3 (en) Cgrp receptor antagonists
DE602004026053D1 (en)
TW200738659A (en) Novel compounds
TW200505903A (en) CGRP receptor antagonists
MX2007008555A (en) Amino-imidazolones for the inhibition of ??-secretase.
UA101478C2 (en) Compounds useful as inhibitors of raf protein kinase
MY164469A (en) Hcv ns3 protease inhibitors
JO3181B1 (en) Derivatives of 1-Phenly -2- Pyridinyl Alkyl alcohols as Phosphodiesterase
JO2578B1 (en) 228 Benzimidazole Thiophene Compounds
EP1615914A4 (en) Cgrp receptor antagonists
TW200724140A (en) Hydantoin compounds
EP1802372A4 (en) Cgrp receptor antagonists
EP1856100A4 (en) Cgrp receptor antagonists
MX2010007543A (en) Inhibitors of iap.
UA96265C2 (en) Composition and method for inhibition of the jak pathway
TW200621260A (en) Selected fused heterocyclics and uses thereof